Q4 25 EPS
$0.01
BEAT +117.51%
Est. $-0.06
Q4 25 Revenue
$223.6M
BEAT +1.25%
Est. $220.8M
vs S&P Since Q4 25
+104.8%
BEATING MARKET
ICHR +110.8% vs S&P +5.9%
Full Year 2025 Results
FY 25 EPS
$0.23
BEAT +35.29%
Est. $0.17
FY 25 Revenue
$947.7M
BEAT +0.29%
Est. $944.9M
Market Reaction
Did ICHR Beat Earnings? Q4 2025 Results
Ichor Holdings closed out Q4 2025 with a better-than-expected performance, delivering non-GAAP EPS of $0.01 against a consensus estimate of negative $0.06, a beat of 116.67%, while revenue of $223.61 million edged past the $220.83 million consensus b… Read more Ichor Holdings closed out Q4 2025 with a better-than-expected performance, delivering non-GAAP EPS of $0.01 against a consensus estimate of negative $0.06, a beat of 116.67%, while revenue of $223.61 million edged past the $220.83 million consensus by 1.26%, even as the top line fell 4.2% year over year amid a broader cyclical trough. The quarter's most material dynamic was the company's ongoing Consolidation Restructuring Plan, which drove a wide gap between GAAP and non-GAAP results; $3.10 million in inventory impairment charges, $2.60 million in fixed asset write-downs, and costs tied to exiting Scotland and Korea operations contributed to a GAAP net loss of $15.96 million, masking the underlying operational improvement CEO Phil Barros described as a demand inflection point. The stock rose roughly 7.7% following the print, with investors responding to Q1 2026 guidance calling for revenue of $240 million to $260 million and non-GAAP EPS of $0.08 to $0.16, as management signaled meaningfully improved gross margins and strong earnings leverage ahead in fiscal 2026.
Key Takeaways
- • Q4 revenue above midpoint of guidance range despite being a trough quarter
- • Full-year 2025 revenue up 11.6% year-over-year to $947.7 million
- • Consolidation Restructuring Plan and Scotland/Korea facility exits drove significant non-GAAP adjustments
- • Q4 non-GAAP gross margin of 11.7%, down from 12.1% in Q3
- • Inventory impairment of $19.8 million for full year 2025 as part of restructuring
- • Working capital improvements with accounts receivable decrease of $13.9 million in Q4
ICHR YoY Financials
Q4 2025 vs Q4 2024, source: SEC Filings
“With Q4 results favorably aligned with our earlier expectations, our focus now shifts to the strengthening demand environment ahead for fiscal 2026. Early indications of customer demand entering the year provide us with a first-quarter revenue outlook reflecting solidly upward momentum from Q4's trough levels. At this time, we expect this upward trend to continue into the second half of the year.”
— Phil Barros, Q4 2025 Earnings Press Release
ICHR Earnings Trends
ICHR vs Market 30 Day Price Reactions
30-day stock return vs benchmark after each earnings
ICHR EPS Trend
Earnings per share: estimate vs actual
ICHR Revenue Trend
Quarterly revenue: estimate vs actual
ICHR Quarterly Results
5 quarters of earnings data
| Quarter | EPS Est. | EPS Act. | Surprise | Revenue | Rev. Surprise |
|---|---|---|---|---|---|
| Q1 26 BEAT | $0.13 | $0.15 | +14.16% | $256.1M | +1.89% |
| Q4 25 BEAT FY | $-0.06 | $0.01 | +117.51% | $223.6M | +1.25% |
| FY Full Year | $0.17 | $0.23 | +35.29% | $947.7M | +0.29% |
| Q3 25 MISS | $0.12 | $0.07 | -40.98% | $239.3M | +1.77% |
| Q2 25 MISS | $0.14 | $0.03 | -79.01% | $240.3M | +2.46% |
| Q1 25 MISS | $0.26 | $0.12 | -54.09% | $244.5M | -0.20% |